MPO and ulcerative colitis: Decreases IL-1β, TNF-α, MDA, MPO, NF-κB p65, TRAF6, LC3, Beclin1, p62 levels and cell apoptosis; increases SOD activity; and exerts obvious therapeutic effect on rat ulcerative colitis.